Abbott Sues To Protect Depakote ER
Abbott’s complaint, dated May 11, was filed in New Jersey against Wockhardt Ltd. and Wockhardt USA.
Depakote, which is indicated for the treatment of bipolar disorder, epilepsy and migraine headaches, brought in $1.3 billion in global sales for Abbott in 2006, according to the company’s annual report.
Tuesday, an Abbott spokesman said...
To view the full article, register now.